| GSK plc. (9/22/22). "Press Release: GSK and Spero Therapeutics Announce Exclusive Licence Agreement for tebipenem HBr, a Late-stage Antibiotic that May Treat Complicated Urinary Tract Infections". London. |
2022-09-22 |
| Adapsyn Bioscience Inc.. (9/21/22). "Press Release: Adapsyn Bioscience Enters into Strategic Collaboration with Evotec". Hamilton, ON. |
2022-09-21 |
| Novo Nordisk Foundation. (9/21/22). "Press Release: Major Investment for Developing Denmark’s First Fully Functional Quantum Computer". |
2022-09-21 |
| Scitara Corporation. (9/20/22). "Press Release: Scitara Announces Partnership with Agilent to Benefit Customers with Enhanced Digital Lab Connectivity". Marlborough, MA. |
2022-09-20 |
| Nuvisan ICB GmbH. (9/20/22). "Press Release: Nuvisan Receives US$ 9.6m Grant for a Multi-target Drug Discovery Program on Novel Non-hormonal Contraceptive Medicines". Berlin. |
2022-09-20 |
| CytoReason Ltd.. (9/20/22). "Press Release: CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development". Tel Aviv. |
2022-09-20 |
| Scailyte AG. (9/19/22). "Press Release: Scailyte Closes Series A Funding with a CHF 6 Million Investment". |
2022-09-19 |
| Aignostics GmbH. (9/15/22). "Press Release: Aignostics Raises €14m Series A to Advance AI-powered Pathology". Berlin. |
2022-09-15 |
| Capstan Therapeutics, Inc.. (9/14/22). "Press Release: Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering". San Diego, CA & Philadelphia, PA. |
2022-09-14 |
| SparingVision S.A.S.. (9/14/22). "Press Release: SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases". |
2022-09-14 |
| Pretzel Therapeutics. (9/12/22). "Press Release: Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies". Waltham, MA. |
2022-09-12 |
| Novo Nordisk A/S. (9/12/22). "Press Release: Novo Nordisk and Microsoft Collaborate to Accelerate Drug Discovery and Development Using Big Data and Artificial Intelligence". Bagsvćrd & Redmond, WA. |
2022-09-12 |
| Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg. |
2022-09-09 |
| AAVantgarde Bio S.r.l.. (9/8/22). "Press Release: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer". Milan. |
2022-09-08 |
| genOway S.A.. (9/8/22). "Press Release: Sigma-Aldrich and genOway Expand Their CRISPR/Cas9 Strategic Alliance". St. Louis, MO & Lyon. |
2022-09-08 |
| MeiraGTx Holdings plc. (9/8/22). "Press Release: MeiraGTx to Participate in Upcoming Investor Conferences". London & New York, NY. |
2022-09-08 |
| Lesaffre & Cie.. (9/7/22). "Press Release: Lesaffre Acquires Recombia Biosciences, a Biotechnology Company Specialized in High-throughput Genome Editing and Synthetic Biology". Paris & San Francisco, CA. |
2022-09-07 |
| Arsenal Biosciences, Inc.. (9/6/22). "Press Release: Arsenal Biosciences Closes $220 Million Series B Financing to Advance Programmable Cell Therapy Programs into Clinical Development". South San Francisco, CA. |
2022-09-06 |
| Bicycle Therapeutics plc. (9/6/22). "Press Release: Bicycle Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference". Cambridge & Boston, MA. |
2022-09-06 |
| ADC Therapeutics S.A.. (9/6/22). "Press Release: ADC Therapeutics to Participate in Morgan Stanley’s 20th Annual Global Healthcare Conference". Lausanne. |
2022-09-06 |
| Pleco Therapeutics B.V.. (9/6/22). "Press Release: Pleco Therapeutics Announces Final Close of Its Series A Financing Raising €17.3m to Progress its Novel Plecoid Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU". Nijmegen. |
2022-09-06 |
| Boehringer Ingelheim. (9/2/22). "Press Release: U.S. FDA Approves First Treatment Option for Generalized Pustular Psoriasis Flares in Adults". Ingelheim. |
2022-09-02 |
| Abivax S.A.. (9/2/22). "Press Release: Abivax Announces Successful Oversubscribed EUR 49.2M Cross-over Financing with Top-tier US and European Biotech Investors [not for US]". Paris. |
2022-09-02 |
| BioEcho Life Sciences GmbH. (9/2/22). "Press Release: BioEcho Life Sciences Announces Expansion with New US Subsidiary". Cologne. |
2022-09-02 |
| Novartis AG. (9/1/22). "Press Release: Novartis Appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., Steps Down from the Executive Committee of Novartis". Basel. |
2022-09-01 |
| Agilent Technologies Inc.. (9/1/22). "Press Release: Agilent Collaborates with Mettler Toledo to Reduce Errors in Sample Preparation Workflows for Better Chromatographic Results". Santa Clara, CA. |
2022-09-01 |
| The Protein Brewery B.V.. (9/1/22). "Press Release: The Protein Brewery Appoints Sue Garfitt as CEO". Breda. |
2022-09-01 |
| Affimed N.V.. (9/1/22). "Press Release: Affimed to Present at Upcoming Investor Conferences". Heidelberg. |
2022-09-01 |
| Novo Nordisk A/S. (9/1/22). "Press Release: Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders". Bagsvćrd & Watertown, MA. |
2022-09-01 |
| Centogene N.V.. (9/1/22). "Press Release: Centogene to Present at Upcoming Investor & Partnering Conferences in September". Cambridge, MA, Rostock & Berlin. |
2022-09-01 |
| Ginkgo Bioworks Inc.. (9/1/22). "Press Release: Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing and Life Science Tools". Boston, MA. |
2022-09-01 |
| BioNTech SE. (9/1/22). "Press Release: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union". New York, NY & Mainz. |
2022-09-01 |
| AiCuris Anti-infective Cures AG. (9/1/22). "Press Release: AiCuris Appoints Experienced Business Leader Dr. Sabrina Kuttruff-Coqui as Chief Financial Officer". Wuppertal. |
2022-09-01 |
| CRISPR Therapeutics AG. (8/31/22). "Press Release: CRISPR Therapeutics to Participate in Upcoming Investor Conferences". Zug & Cambridge, MA. |
2022-08-31 |
| BioNTech SE. (8/31/22). "Press Release: Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older". New York, NY & Mainz. |
2022-08-31 |
| MorphoSys AG. (8/31/22). "Press Release: MorphoSys Appoints Tim Demuth as New Chief Research and Development Officer, Following the Retirement of Malte Peters". Planegg. |
2022-08-31 |
| Ori Biotech Ltd.. (8/30/22). "Press Release: Ori Biotech Adds to Senior Team, Scientific Advisory Board and Expands Global Footprint". London. |
2022-08-30 |
| Moderna, Inc.. (8/26/22). "Press Release: Moderna Sues Pfizer and BioNTech for Infringing Patents Central to Moderna's Innovative mRNA Technology Platform". Cambridge, MA. |
2022-08-26 |
| Novartis AG. (8/25/22). "Press Release: Novartis Announces Intention to Separate Sandoz Business to Create a Standalone Company by Way of a 100% Spin-off". Basel. |
2022-08-25 |
| ElevateBio, LLC. (8/25/22). "Press Release: ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene Therapy Innovation". Pittsburgh, PA. |
2022-08-25 |
| eTheRNA Immunotherapeutics N.V.. (8/23/22). "Press Release: mRNA Leading Expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA". Niel. |
2022-08-23 |
| ElevateBio, LLC. (8/23/22). "Press Release: ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines". Waltham, MA. |
2022-08-23 |
| Immatics N.V.. (8/23/22). "Press Release: Immatics Announces First Cancer Patient Treated with Second-generation ACTengine TCR-T Candidate IMA203CD8 Targeting PRAME". Houston, TX & Tübingen. |
2022-08-23 |
| Kinarus Therapeutics Holding AG. (8/22/22). "Press Release: Kinarus Announces the Issuance of Convertible Notes of up to CHF 20 Million to an Entity Managed by Yorkville [ not for any jurisdiction where unlawful]". Basel. |
2022-08-22 |
| Adelis Equity Partners. (8/22/22). "Press Release: Adelis Equity Partners Raises Fund Continuation Vehicle for SSI Diagnostica Group, Enabling Transformational Acquisition". |
2022-08-22 |
| Ampersand Capital Partners. (8/22/22). "Press Release: Ampersand Closes Oversubscribed Fund at $1.2 Billion Hard Cap". Wellesley, MA. |
2022-08-22 |
| SSI Diagnostica A/S. (8/22/22). "Press Release: SSI Diagnostica Continues Strong Growth Journey by Merging with Virginia-based TechLab". |
2022-08-22 |
| BioNTech SE. (8/22/22). "Press Release: Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine". New York, NY & Mainz. |
2022-08-22 |
| Ginkgo Bioworks Inc.. (8/19/22). "Press Release: Ginkgo Bioworks Announces Strategic Purchase of Epidemiological Data Infrastructure Assets". Boston, MA. |
2022-08-19 |
| Valneva S.E.. (8/18/22). "Press Release: Valneva Provides Update on Ixiaro Supply Contract with U.S. Department of Defense". Saint-Herblain. |
2022-08-18 |
| Rentschler Biopharma SE. (8/18/22). "Press Release: Rentschler Biopharma Appoints Mark Caswell as Vice President, Site Head for US Facility". Laupheim & Milford, MA. |
2022-08-18 |
| Moderna, Inc.. (8/17/22). "Press Release: James Mock Joins Moderna as Chief Financial Officer". Cambridge, MA. |
2022-08-17 |
| Eurobio Scientific S.A.. (8/17/22). "Press Release: Eurobio Scientific Signs an Agreement to Acquire GenDx, International HLA Diagnostics Specialist". Paris. |
2022-08-17 |
| ChemDiv, Inc.. (8/11/22). "Press Release: ChemDiv and Jacobs University Announce Strategic Partnership in Drug Discovery". San Diego, CA & Bremen. |
2022-08-11 |
| Vector BioPharma AG. (8/10/22). "Press Release: Versant Ventures Launches Vector BioPharma AG". Basel. |
2022-08-10 |
| Immatics N.V.. (8/9/22). "Press Release: Immatics Announces Second Quarter 2022 Financial Results and Business Update". Tübingen & Houston, TX. |
2022-08-09 |
| Navis Capital Partners. (8/9/22). "Press Release: Navis Capital Partners Announces the Sale of 100% of B Medical Systems to Azenta, Inc". Singapore. |
2022-08-09 |
| Global Blood Therapeutics, Inc.. (8/8/22). "Press Release: Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology". New York, NY & South San Francisco, CA. |
2022-08-08 |
| BioNTech SE. (8/8/22). "Press Release: BioNTech Announces Second Quarter Financial Results and Corporate Update". Mainz. |
2022-08-08 |
| Valneva S.E.. (8/8/22). "Press Release: Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15". New York, NY & Saint-Herblain. |
2022-08-08 |
| Azenta, Inc.. (8/8/22). "Press Release: Azenta Announces Agreement to Acquire B Medical Systems". Chelmsford, MA. |
2022-08-08 |
| BioNTech SE. (8/5/22). "Press Release: BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates". Mainz & Copenhagen. |
2022-08-05 |
| ElevateBio, LLC. (8/4/22). "Press Release: ElevateBio Announces the Formation of a New Company with George Daley, M.D., Ph.D., and Boston Children’s Hospital to Develop iPSC-Derived Allogeneic Immune Therapies". Waltham, MA. |
2022-08-04 |
| Amgen Inc.. (8/4/22). "Press Release: Amgen to Acquire ChemoCentryx for $4 Billion in Cash". Thousand Oaks, CA & San Carlos, CA. |
2022-08-04 |
| Roslin Cell Therapies Ltd. (RoslinCT). (8/4/22). "Press Release: RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO". Edinburgh & Hopkinton, MA. |
2022-08-04 |
| Wyss Institute for Biologically Inspired Engineering at Harvard University. (8/4/22). "Press Release: 3EO Health Licenses Wyss Institute Technology from Harvard, Aiming to Develop At-home Molecular Testing with PCR-grade Sensitivity and Antigen Test-leve |
2022-08-04 |
| F2G Ltd.. (8/4/22). "Press Release: F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim". Manchester. |
2022-08-04 |
| Congenica Ltd.. (8/4/22). "Press Release: GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution". Cambridge & Cleveland, OH. |
2022-08-04 |
| MiroBio Ltd.. (8/4/22). "Press Release: Gilead Sciences to Acquire MiroBio". Foster City, CA & Oxford. |
2022-08-04 |
| Formycon AG. (8/3/22). "Press Release: U.S. Food and Drug Administration (FDA) Approved FYB201/Cimerli (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis". Munich, Amsterdam & Zug. |
2022-08-03 |
| Pfizer Inc.. (8/3/22). "Press Release: Pfizer to Discontinue Development Program for PF-07265803 for LMNA-Related Dilated Cardiomyopathy". New York, NY. |
2022-08-03 |
| Poseida Therapeutics, Inc.. (8/3/22). "Press Release: Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies". San Diego, CA. |
2022-08-03 |
| Bio-Rad Laboratories, Inc.. (8/3/22). "Press Release: Bio-Rad Acquires Curiosity Diagnostics". Hercules, CA. |
2022-08-03 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (8/2/22). "Press Release: Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases". Tokyo & Cambridge. |
2022-08-02 |
| S-Biomedic N.V.. (8/2/22). "Press Release: S-Biomedic Welcomes Pascal Yvon to Lead Its B2B Commercial Activities". Beerse. |
2022-08-02 |
| Eleven Therapeutics. (8/2/22). "Press Release: Eleven Therapeutics Announces $22 Million in Seed Funding. Round Includes $9 Million from the Bill & Melinda Gates Foundation". Tel Aviv & Cambridge. |
2022-08-02 |
| MDxHealth S.A.. (8/2/22). "Press Release: MDxHealth Acquires Oncotype DX GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results". Irvine, CA & Herstal. |
2022-08-02 |
| ResMed Inc.. (8/2/22). "Press Release: ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio". Martinsried & Leipzig. |
2022-08-02 |
| Cleerly, Inc.. (7/28/22). "Press Release: Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million [updated version of press release from 25 July]". New York, NY. |
2022-07-28 |
| Ryvu Therapeutics S.A.. (7/26/22). "Press Release: Ryvu Therapeutics Announces Promotion of Hendrik Nogai and Vatnak Vat-Ho to the Management Board". Kraków. |
2022-07-26 |
| Replay Holdings LLC. (7/25/22). "Press Release: Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA". San Diego, CA & London. |
2022-07-25 |
| Ginkgo Bioworks Inc.. (7/25/22). "Press Release: Ginkgo to Acquire Zymergen. Acquisition Is Expected to Accelerate the Development of Ginkgo's Innovative Horizontal Synthetic Biology Platform". Boston, MA & Emeryville, CA. |
2022-07-25 |
| NewAmsterdam Pharma Holding B.V.. (7/25/22). "Press Release: NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Oral Therapies for Cardiometabolic Disea |
2022-07-25 |
| NeoSphere Biotechnologies GmbH. (7/25/22). "Press Release: NeoSphere Biotechnologies Closes Financing Round to Expand Proteomics Platform for Systematic Identification of Novel Targets for Targeted Protein Degradation". Munich. |
2022-07-25 |
| Ginkgo Bioworks Inc.. (7/25/22). "Press Release: Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities". Boston, MA. |
2022-07-25 |
| Amazon. (7/21/22). "Press Release: Amazon and One Medical Sign an Agreement for Amazon to Acquire One Medical". Seattle, WA & San Francisco, CA. |
2022-07-21 |
| Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent
". Aubagne. |
2022-07-21 |
| Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying
EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen. |
2022-07-21 |
| Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Hřngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden. |
2022-07-20 |
| Immunocore Holdings plc. (7/18/22). "Press Release: Immunocore Announces $140 Million Private Placement Financing". Oxfordshire, Conshohocken, PA & Rockville, MD. |
2022-07-18 |
| Oxford Science Park, The. (7/18/22). "Press Release: The Oxford Science Park Agrees to Sale of Development Site to the Lawrence J. Ellison Institute for Transformative Medicine". Oxford. |
2022-07-18 |
| Delfi Diagnostics, Inc.. (7/18/22). "Press Release: Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests". Baltimore, MD & Palo Alto, CA. |
2022-07-18 |
| Forty51 Ventures. (7/18/22). "Press Release: Forty51 Ventures Announces the First Close of Fund I and its First Investment". Luxembourg & Basel. |
2022-07-18 |
| Enterome S.A.. (7/18/22). "Press Release: Enterome Signs Major Strategic R&D Collaboration with Nestlé Health Science to Develop and Commercialize New AllerMimics and EndoMimics Immunotherapies for Food Allergies and Inflammatory Bowel Disease". Paris. |
2022-07-18 |
| Rubius Therapeutics, Inc.. (7/14/22). "Press Release: Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors". Cambridge, MA. |
2022-07-14 |
| Manifold Biotechnologies, Inc.. (7/14/22). "Press Release: Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design Platform". Boston, MA. |
2022-07-14 |
| IZB Martinsried. (7/14/22). "Press Release: Cutting-edge Research at Munich’s IZB Attracts Strong Interest". Martinsried. |
2022-07-14 |
| BeiGene, Ltd.. (7/13/22). "Press Release: BeiGene Appoints Chan Lee as General Counsel". Cambridge, MA, Basel & Beijing. |
2022-07-13 |
| Agomab Therapeutics N.V.. (7/13/22). "Press Release: Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million". Ghent. |
2022-07-13 |
| Delfi Diagnostics, Inc.. (7/12/22). "Press Release: Jessica Meng Joins Delfi Diagnostics as Chief Commercial Officer". Baltimore, MD. |
2022-07-12 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
